Dr RR Baliga's "Got Knowledge Doc" Podkast

🫀 MI has been redefined—and the numbers are gone.

The Fifth Universal Definition of Myocardial Infarction (2026) replaces the familiar numerical MI types with a clinically intuitive trio:

🔴 Primary MI — acute coronary pathology 🟢 Secondary MI — supply–demand imbalance from another acute illness 🔵 Procedure-related MI — complication of a cardiac procedure

The crucial message? 🩸 Troponin elevation is myocardial injury—not automatically MI. Context, ischemia, ECG and imaging matter.

🎙️ Dr RR Baliga's Podkast for the Curious Doc: Where Curiosity Meets Clarity!

🫀💊 Can 4 doses help protect the kidney after cardiac surgery?

MERCURI-2 randomized 784 patients to perioperative dapagliflozin or placebo. AKI within 7 days fell from 52% to 28%—RR 0.54, an absolute reduction of ~24% and NNT ≈4. 📉

Intriguingly, the signal was driven largely by urine-output–defined AKI; creatinine-only AKI was unchanged. Hard 30-day outcomes were also unchanged.

🎙️ A provocative new chapter in perioperative cardiorenal protection. 🛡️

💉 Shingles Shot, Heart Shield? 🛡️❤️

Could recombinant shingles vaccination protect more than the skin? In a natural experiment involving >72,000 matched adults ≥60 years, the recombinant vaccine was associated with 9% lower cardiovascular disease burden over 7 years, including lower burdens of ischemic heart disease and heart failure. 📉🫀

💡 Intriguingly, AS01-induced immune reprogramming and reduced IL-6 responses offer a potential mechanistic clue.

⚠️ Association ≠ causation—but this signal deserves randomized trials.

#Cardiology #Vaccines #Prevention #MedicalPodcasts

🔎 Can you believe that meta-analysis?

Meta-analyses sit near the summit of evidence-based medicine—but pooling more studies does not automatically produce more truth. 📊

Lee and colleagues offer a powerful clinical lesson: credibility requires alignment of evidence, methods, and inference. Ask first: Should these studies have been pooled at all? 🧠

Look for prospective planning, robust source data, adequate events, explainable heterogeneity, transparency, and honest uncertainty.

🎯 The goal? Fewer, better, more believable meta-analyses.

🩺 Avicenna: Medicine, Mind & a Millennium of Influence

Nearly 1,000 years ago, Ibn Sina—Avicenna—was already asking questions that still animate medicine: How should we observe disease? How do reason and experience guide diagnosis? How are mind and body connected? 🧠

His monumental Canon of Medicine traveled from the Islamic world into European universities and influenced generations of physicians. 📖🌍

Meet the physician, philosopher & polymath whose curiosity refused to stay in one discipline.

🎙️ Great Doctors Series | Podkast for the Kurious Doc

🎯 Target the Tumor, Guard the Heart! ❤️

Antibody-drug conjugates are transforming breast cancer therapy—but precision oncology does not eliminate cardiovascular risk. 🧬🫀

This excellent JACC: CardioOncology Primer explores how the antibody, linker & payload may contribute to cardiotoxicity. HER2-directed ADCs carry the clearest cardiac signal, with T-DXd showing higher and more variable LVEF decline than T-DM1, while TROP-2–directed ADCs currently show limited cardiac signals.

🔑 The future: risk-based surveillance, biomarkers, AI prediction & smarter ADC engineering.

#CardioOncology #BreastCancer #ADCs #Cardiotoxicity #MedicalPodcasts

🫀 Can vascular injury begin in your early 20s? Apparently, yes. In 1,283 young adults (mean age 22.9 years), ~79% had Stage 1–3 Cardiovascular-Kidney-Metabolic (CKM) syndrome.

Higher CKM stage tracked with poorer Life's Essential 8 scores and greater carotid arterial injury.

🚨 Strikingly, even Stage 1—excess adiposity—was associated with thicker carotid intima-media.

🎯 The message for clinicians: young adulthood is not a vascular grace period. Primordial prevention must start early.

⏳ Can we measure aging before disease arrives?

A fascinating Nature Medicine analysis puts epigenetic aging clocks to the test. Across 51 intervention studies and 3,128 blood samples, reliable next-generation clocks—particularly DunedinPACE and PCGrimAge—were the most responsive. 🧬 Pharmacologic interventions generated especially strong signals.

Responsiveness of epigenetic aging biomarkers to longevity interventions in humans.pdf

But here is the clinical pearl: a clock moving backward does not yet prove that the patient will live longer or healthier. ⚠️ Responsiveness is necessary for surrogacy—but not sufficient.

News and Views Putting epigenetic aging clocks on trial.pdf

🎙️ Dr RR Baliga's Podkast for the Kurious Doc. Where Curiosity Meets Clarity!

🧬 Why do some people reach 100+ with remarkable resilience? Centenarians don't simply escape immune aging—they appear to adapt to it.

Preserved NK-cell function, altered T-cell populations, delayed autophagy decline, modulation of inflammageing, and distinctive transcriptomic, epigenetic and gut-microbial signatures may help maintain immune homeostasis. 💯🛡️

Fascinating lessons from nature's longest-lived humans—and perhaps clues for extending healthspan, not merely lifespan. 🔬♻️

🎨 Repigment, Reframe, Restore: A New Era for Vitiligo

Vitiligo is far more than a cosmetic condition. In two phase 3 Viti-Up trials, oral upadacitinib 15 mg significantly improved facial and total-body repigmentation at 48 weeks. 💊

But here is the deeper lesson: better pigmentation ≠ complete patient benefit. Only 13–15% reported their vitiligo as "a lot less" or "no longer" noticeable. 👁️

The future of vitiligo care must measure not only pigment, but also dignity, mental health, long-term safety and access. 🧠❤️

#Vitiligo #Dermatology #JAKInhibitors #MedicalPodcasts